Article info

Download PDFPDF
Predicting the likelihood of a BRCA1/2 pathogenic variant being somatic by testing only tumour DNA in non-mucinous high-grade epithelial ovarian cancer

Authors

  1. Correspondence to Dr Robert D Morgan, Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester M20 4BX, UK; robert.morgan7{at}nhs.net
View Full Text

Citation

Morgan RD, Burghel GJ, Flaum N, et al
Predicting the likelihood of a BRCA1/2 pathogenic variant being somatic by testing only tumour DNA in non-mucinous high-grade epithelial ovarian cancer

Publication history

  • Received May 2, 2022
  • Accepted June 9, 2022
  • First published June 23, 2022.
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.